The DOI matches its Crossref record; 126 of the 129 references it cites were found in a registry or an index.
Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis
Open accessAbstract
OBJECTIVE: Osteoarthritis (OA) is a chronic and slowly progressive disease for which biomarkers may be able to provide a more rapid indication of therapeutic responses to therapy than is currently available; this could accelerate and facilitate OA drug discovery and development programs. The goal of this document is to provide a summary and guide to the application of in vitro (biochemical and other soluble) biomarkers in the development of drugs for OA and to outline and stimulate a research agenda that will further this goal. METHODS: The Biomarkers Working Group representing experts in the field of OA biomarker research from both academia and industry developed this consensus document between 2007 and 2009 at the behest of the Osteoarthritis Research Society International Federal Drug Administration initiative (OARSI FDA initiative). RESULTS: This document summarizes definitions and classification systems for biomarkers, the current outcome measures used in OA clinical trials, applications and potential utility of biomarkers for development of OA therapeutics, the current state of qualification of OA-related biomarkers, pathways for biomarker qualification, critical needs to advance the use of biomarkers for drug development, recommendations regarding practices and clinical trials, and a research agenda to advance the science of OA-related biomarkers. CONCLUSIONS: Although many OA-related biomarkers are currently available they exist in various states of qualification and validation. The biomarkers that are likely to have the earliest beneficial impact on clinical trials fall into two general categories, those that will allow targeting of subjects most likely to either respond and/or progress (prognostic value) within a reasonable and manageable time frame for a clinical study (for instance within 1-2 years for an OA trial), and those that provide early feedback for preclinical decision-making and for trial organizers that a drug is having the desired biochemical effect. As in vitro biomarkers are increasingly investigated in the context of specific drug treatments, advances in the field can be expected that will lead to rapid expansion of the list of available biomarkers with increasing understanding of the molecular processes that they represent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“By synthesizing information from circulating biomarkers, synovial fluid analysis, quantitative imaging parameters, and clinical evaluation, an integrated framework can help facilitate holistic orthopedic care and enable clinicians to detect disease earlier, stratify patients according to disease subtypes, predict progression trajectories, and monitor therapeutic responses with greater precision [9”
From Biomarker-Guided Imaging and AI-Augmented Diagnosis of Degenerative Joint Disease (2025) · cites this paper as [10]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radiological Assessment of Osteo-Arthrosis
Kellgren, J., & Lawrence, J. S. (1957) · Annals of the Rheumatic Diseases · doi:10.1136/ard.16.4.494 · Cited by 12,472
Altman, R., Asch, E., Bloch, D., Bole, G., Borenstein, D., Brandt, K., Christy, W., Cooke, T. D., Greenwald, R., Hochberg, M., et al. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780290816 · Cited by 6,777
Self-citationBiomarkers and surrogate endpoints: Preferred definitions and conceptual framework
Biomarkers Definitions Working Group (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.113989 · Cited by 6,771
Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative.
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Lijmer, J. G., Moher, D., Rennie, D., de Vet, H. C. W., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-1-200301070-00010 · Cited by 3,219
Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Lijmer, J. G., Moher, D., Rennie, D., & de Vet, H. C. W. (2003) · BMJ · doi:10.1136/bmj.326.7379.41 · Cited by 3,215
Altman, R. D., Alarcón, G. S., Appelrouth, D. J., Bloch, D. A., BORENSTEIN, D. G., Brandt, K. D., Brown, C., Cooke, T. D. V., Daniel, W., Feldman, D. P., et al. (1991) · Arthritis & Rheumatism · doi:10.1002/art.1780340502 · Cited by 2,631
Abraham, J. M. (2010) · Brill | Nijhoff eBooks · doi:10.1163/ej.9789004163300.i-1081.897 · Cited by 2,612
Altman, R. D., Alarcón, G. S., Appelrouth, D. J., Bloch, D. A., BORENSTEIN, D. G., Brandt, K. D., Brown, C., Cooke, T. D. V., Daniel, W., Gray, R., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780331101 · Cited by 1,130
Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage.
Billinghurst, R. C., Dahlberg, L., Ionescu, M., Reiner, A., Bourne, R., Rorabeck, C. H., Mitchell, P. G., Hambor, J., Diekmann, O., Tschesche, H., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119316 · Cited by 970
Self-citationPham, T., van der Heijde, D. M. F. M., Altman, R. D., Anderson, J. J., Bellamy, N., Hochberg, M. C., Simon, L. S., Strand, V., Woodworth, T., & Dougados, M. (2004) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2004.02.001 · Cited by 849
Bellamy, N., Kirwan, J., Boers, M., Brooks, P., Strand, V., Tugwell, P., Altman, R. D., Brandt, K. D., Dougados, M., & Lequesne, M. G. (1997) · PubMed · Cited by 745
Hollander, A. P., Heathfield, T. F., Webber, C. A., Iwata, Y., Bourne, R., Rorabeck, C. H., & Poole, A. R. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117156 · Cited by 611
Self-citationLesko, L., & Atkinson, A. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.347 · Cited by 465
Uebelhart, D., Gineyts, É., Chapuy, M. C., & Delmas, P. D. (1990) · Bone and Mineral · doi:10.1016/0169-6009(91)90143-n · Cited by 423
Classification of osteoarthritis biomarkers: a proposed approach
Bauer, D. C., Hunter, D. J., Abramson, S. B., Attur, M., Corr, M., Felson, D., Heinegård, D., Jordan, J. M., Kepler, T. B., Lane, N. E., et al. (2006) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2006.04.001 · Cited by 405
Self-citationGarnero, P., Ayral, X., Rousseau, J., Christgau, S., Sandell, L. J., Dougados, M., & Delmas, P. D. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10576 · Cited by 395
Self-citationBingham, C. O., Buckland‐Wright, J. C., Garnero, P., Cohen, S. B., Dougados, M., Adami, S., Clauw, D. J., Spector, T. D., Pelletier, J., Raynauld, J., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22160 · Cited by 373
Self-citationCOMP Acts as a Catalyst in Collagen Fibrillogenesis
Halász, K., Kassner, A., Mörgelin, M., & Heinegård, D. K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705735200 · Cited by 328
Self-citationQuantification of keratan sulfate in blood as a marker of cartilage catabolism
Thonar, E. J. ‐. A., Lenz, M. E., Klintworth, G. K., Caterson, B., Pachman, L. M., Glickman, P. B., Katz, R. S., Huff, J. P., & Kuettner, K. E. (1985) · Arthritis & Rheumatism · doi:10.1002/art.1780281209 · Cited by 311
Evidence for altered synthesis of type II collagen in patients with osteoarthritis.
Nelson, F. R. T., Dahlberg, L., Laverty, S., Reiner, A., Pidoux, I., Ionescu, M., Fraser, G. L., Brooks, E., Tänzer, M., Rosenberg, L. C., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci4853 · Cited by 297
Self-citationCollagen type II C-telopeptide fragments as an index of cartilage degradation
Christgau, S., Garnero, P., Fledelius, C., Moniz, C., Ensig, M., Gineyts, É., Rosenquist, C., & Qvist, P. (2001) · Bone · doi:10.1016/s8756-3282(01)00504-x · Cited by 285
Self-citationChange in joint space width: Hyaline articular cartilage loss or alteration in meniscus?
Hunter, D. J., Zhang, Y., Tu, X., LaValley, M. P., Niu, J., Amin, S., Guermazi, A., Genant, H. K., Gale, D. R., & Felson, D. T. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22016 · Cited by 280
Lane, N. E., Nevitt, M. C., Genant, H. K., & Hochberg, M. C. (1993) · PubMed · Cited by 276
Quantitative Urinary Proteome Analysis for Biomarker Evaluation in Chronic Kidney Disease
Siwy, J., Schiffer, E., Brand, K., Schumann, G., Rossing, K., Delles, C., Mischak, H., & Metzger, J. (2008) · Journal of Proteome Research · doi:10.1021/pr800401m · Cited by 259
Walakovits, L. A., Moore, V. L., Bhardwaj, N., Gallick, G. S., & Lark, M. W. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780350106 · Cited by 257
Rizkalla, G., Reiner, A., Bogoch, E. R., & Poole, A. R. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116113 · Cited by 251
Self-citationSpector, T. D., Conaghan, P. G., Buckland-Wright, J. C., Garnero, P., Cline, G. A., Beary, J. F., Valent, D. J., & Meyer, J. M. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1716 · Cited by 237
Self-citationBiological markers in osteoarthritis
Rousseau, J.-C., & Delmas, P. D. (2007) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0508 · Cited by 237
Self-citationvan Spil, W. E., DeGroot, J., Lems, W. F., Oostveen, J. C. M., & Lafeber, F. P. J. G. (2010) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2010.01.012 · Cited by 207
Wagner, J. A., Williams, S., & Webster, C. J. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100017 · Cited by 201
Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: a pilot study
Uebelhart, D., Thonar, E. J. ‐. A., Delmas, P. D., Chantraine, A., & Vignon, E. P. (1998) · Osteoarthritis and Cartilage · doi:10.1016/s1063-4584(98)80011-3 · Cited by 196
Lee, J. W., WEINER, R. S., Sailstad, J. M., Bowsher, R. R., Knuth, D. W., O'Brien, P. J., Fourcroy, J. L., Dixit, R., Pandite, L. N., Pietrusko, R. G., et al. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-2495-9 · Cited by 194
Emrani, P. S., Katz, J. N., Kessler, C. L., Reichmann, W. M., Wright, E. A., McAlindon, T. E., & Losina, E. (2008) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2007.12.004 · Cited by 188
Yoshida, K., Miyauchi, S., Kikuchi, H., Tawada, A., & Tokuyasu, K. (1989) · Analytical Biochemistry · doi:10.1016/0003-2697(89)90061-4 · Cited by 180
Diurnal variation of serum and urine biomarkers in patients with radiographic knee osteoarthritis
Kong, S., Stäbler, T., Criscione‐Schreiber, L. G., Elliott, A. L., Jordan, J. M., & Kraus, V. B. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21977 · Cited by 162
Self-citationThe disease modifying osteoarthritis drug (DMOAD): Is it in the horizon?☆
Qvist, P., Bay‐Jensen, A., Christiansen, C., Dam, E. B., Pastoureau, P., & Karsdal, M. A. (2008) · Pharmacological Research · doi:10.1016/j.phrs.2008.06.001 · Cited by 160
Oestergaard, S., Sondergaard, B. C., Høegh-Andersen, P., Henriksen, K., Qvist, P., Christiansen, C., Tankó, L. B., & Karsdal, M. A. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22009 · Cited by 157
Biomarker qualification pilot process at the US Food and Drug Administration
Goodsaid, F. M., & Frueh, F. W. (2007) · The AAPS Journal · doi:10.1208/aapsj0901010 · Cited by 155
Cytotoxicity of T-2 toxin and its metabolites determined with the neutral red cell viability assay
Babich, H., & Borenfreund, E. (1991) · Applied and Environmental Microbiology · doi:10.1128/aem.57.7.2101-2103.1991 · Cited by 153
Sharif, M., Kirwan, J., Elson, C. J., Granell, R., & Clarke, S. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20365 · Cited by 153
Quantitation of chondroitin 4—sulfate and chondroitin 6—sulfate in pathologic joint fluid
Shinmei, M., Miyauchi, S., MACHIDA, A., & Miyazaki, K. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780351110 · Cited by 152
Eckstein, F., Maschek, S., Wirth, W., Hudelmaier, M. I., Hitzl, W., Wyman, B. T., Nevitt, M. C., & Graverand, M.-P. H. L. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.089904 · Cited by 147
Huebner, J. L., Hanes, M. A., Beekman, B., TeKoppele, J. M., & Kraus, V. B. (2002) · Osteoarthritis and Cartilage · doi:10.1053/joca.2002.0821 · Cited by 141
Self-citationCibere, J., Zhang, H., Garnero, P., Poole, A. R., Lobanok, T., Saxne, T., Kraus, V. B., Way, A., Thorne, A., Wong, H., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24473 · Cited by 140
Self-citationPoole, A. R., Ionescu, M., Fitzcharles, M., & Billinghurst, R. C. (2004) · Journal of Immunological Methods · doi:10.1016/j.jim.2004.09.005 · Cited by 140
Self-citationGerlach, R. F., Uzuelli, J. A., Demacq, C., & Tanus-Santos, J. E. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2005.04.038 · Cited by 137
Karsdal, M. A., Henriksen, K., Leeming, D. J., Mitchell, P. G., Duffin, K. L., Barascuk, N., Klickstein, L. B., Aggarwal, P., Nemirovskiy, O. V., Byrjalsen, I., et al. (2009) · Biomarkers · doi:10.1080/13547500902777608 · Cited by 136
Manicourt, D., Azria, M., Mindeholm, L., Thonar, E. J. ‐., & Devogelaer, J. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22075 · Cited by 135
Abadie, E., Ethgen, D. J., Avouac, B. P., Bouvenot, G., Branco, J., Bruyère, O., Calvo, G., Devogelaer, J.-P., Dreiser, R.-L., Herrero‐Beaumont, G., et al. (2004) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2004.01.006 · Cited by 131
Lassere, M. N., Johnson, K. R., Boers, M., Tugwell, P., Brooks, P., Simon, L. S., Strand, V., Conaghan, P. G., Østergaard, M., Maksymowych, W. P., et al. (2007) · PubMed · Cited by 125
Mazières, B., Hucher, M., Zaïm, M., & Garnero, P. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.059899 · Cited by 124
Self-citationBuckland‐Wright, J. C., Messent, E. A., Bingham, C. O., Ward, R. J., & Tonkin, C. J. (2006) · Lara D. Veeken · doi:10.1093/rheumatology/kel213 · Cited by 122
Jordan, J. M., Luta, G., Stäbler, T., Renner, J. B., Dragomir, A. D., Vilı́m, V., Hochberg, M. C., Helmick, C. G., & Kraus, V. B. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10822 · Cited by 122
Self-citationAndersson, M., Thorstensson, C. A., Roos, E. M., Petersson, I. F., Heinegård, D. K., & Saxne, T. (2006) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-7-98 · Cited by 122
Self-citationIdentification of progressors in osteoarthritis by combining biochemical and MRI-based markers
Dam, E. B., Loog, M., Christiansen, C., Byrjalsen, I., Folkesson, J., Nielsen, M., Qazi, A. A., Pettersen, P. C., Garnero, P., & Karsdal, M. A. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2774 · Cited by 116
Self-citationBanking of Biological Fluids for Studies of Disease-associated Protein Biomarkers
Schrohl, A., Würtz, S. Ø., Kohn, E. C., Banks, R. E., Nielsen, H. J., Sweep, F. C. G. J., & Bruünner, N. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r800010-mcp200 · Cited by 109
Trabecular morphometry by fractal signature analysis is a novel marker of osteoarthritis progression
Kraus, V. B., Feng, S., Wang, S., White, S., Ainslie, M., Brett, A., Holmes, A., & Charles, H. C. (2009) · Arthritis & Rheumatism · doi:10.1002/art.25012 · Cited by 108
Self-citationType II collagen markers in osteoarthritis: what do they indicate?
Henrotin, Y., Addison, S., Kraus, V., & Deberg, M. (2007) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32829fb3b5 · Cited by 108
Self-citationMeulenbelt, I., Kloppenburg, M., Kroon, H. M., Houwing‐Duistermaat, J. J., Garnero, P., Graverand, M.-P. H. L., DeGroot, J., & Slagboom, P. E. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.040642 · Cited by 107
Self-citationKellgren & Lawrence grade 1 osteophytes in the knee—doubtful or definite?
Hart, D. J., & Spector, T. D. (2003) · Osteoarthritis and Cartilage · doi:10.1053/joca.2002.0853 · Cited by 106
Strategic paths for biomarker qualification
Goodsaid, F. M., Frueh, F. W., & Mattes, W. B. (2008) · Toxicology · doi:10.1016/j.tox.2007.12.023 · Cited by 104
Aurich, M. E., Squires, G. R., Reiner, A., Mollenhauer, J. A., Kuettner, K. E., Poole, A. R., & Cole, A. A. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20740 · Cited by 101
Self-citationCahue, S., Sharma, L., Dunlop, D. D., Ionescu, M., Song, J., Lobanok, T., King, L., & Poole, A. R. (2007) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2007.01.016 · Cited by 97
Self-citationThe drug diagnostic co-development concept paper
Hinman, L. M., Sm, H., Hackett, J., Koch, W. H., Love, P. Y., Pennello, G. A., Torres‐Cabassa, A., & Webster, C. (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500392 · Cited by 88
Garnero, P., Aronstein, W. S., Cohen, S. B., Conaghan, P. G., Cline, G. A., Christiansen, C., Beary, J. F., Meyer, J. M., & Bingham, C. O. (2007) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2007.10.002 · Cited by 87
Self-citationNemirovskiy, O. V., Dufield, D. R., Sunyer, T., Aggarwal, P., Welsch, D., & Mathews, W. R. (2006) · Analytical Biochemistry · doi:10.1016/j.ab.2006.10.034 · Cited by 85
First Qualification Study of Serum Biomarkers as Indicators of Total Body Burden of Osteoarthritis
Kraus, V. B., Kepler, T. B., Stäbler, T., Renner, J. B., & Jordan, J. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009739 · Cited by 85
Self-citationGuidance for Industry: Pharmacogenomic Data Submissions
(2004) · Biotechnology Law Report · doi:10.1089/073003104322838303 · Cited by 82
Urea as a passive transport marker for arthritis biomarker studies
Kraus, V. B., Huebner, J. L., Fink, C., King, J. B., Brown, S. A., Vail, T. P., & Guilak, F. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10124 · Cited by 81
Self-citationGarnero, P., Sornay‐Rendu, E., ARLOT, M. E., Christiansen, C., & Delmas, P. D. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20493 · Cited by 79
Self-citationAssessment of the utility of biomarkers of osteoarthritis in the guinea pig
Huebner, J. L., & Kraus, V. B. (2006) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2006.03.007 · Cited by 78
Self-citationChristgau, S., Henrotin, Y. E., Tankó, L. B., Rovati, L. C., Collette, J., Bruyère, O., Deroisy, R., & Reginster, J. (2004) · PubMed · Cited by 78
Self-citationBay‐Jensen, A., Andersen, T. L., Tabassi, N. C.-B., Kristensen, P. W., Kjærsgaard‐Andersen, P., Sandell, L. J., Garnero, P., & Delaissé, J. (2007) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2007.09.006 · Cited by 78
Self-citationNovel synovial fluid recovery method allows for quantification of a marker of arthritis in mice
Seifer, D. R., Furman, B. D., Guilak, F., Olson, S. A., Brooks, S. C., & Kraus, V. B. (2008) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2008.04.013 · Cited by 77
Self-citationSoy protein may alleviate osteoarthritis symptoms
Arjmandi, B. H., Khalil, D. A., Lucas, E. A., Smith, B. J., Sinichi, N., Hodges, S. B., Juma, S., Munson, M. E., Payton, M. E., Tivis, R. D., et al. (2004) · Phytomedicine · doi:10.1016/j.phymed.2003.11.001 · Cited by 75
Lohmander, S. L., Brandt, K. D., Mazzuca, S. A., Katz, B. P., Larsson, S., Struglics, A., & Lane, K. A. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21345 · Cited by 75
Tabassi, N. C.-B., Desmarais, S., Bay‐Jensen, A., Delaissé, J., Percival, M. D., & Garnero, P. (2008) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2008.02.008 · Cited by 73
Self-citationProcess Map Proposal for the Validation of Genomic Biomarkers
Goodsaid, F. M., & Frueh, F. W. (2006) · Pharmacogenomics · doi:10.2217/14622416.7.5.773 · Cited by 73
Serum protein signatures detect early radiographic osteoarthritis
Ling, S. M., Patel, D. D., Garnero, P., Zhan, M., Vaduganathan, M., Muller, D., Taub, D. D., Bathon, J. M., Hochberg, M., Abernethy, D. R., et al. (2008) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2008.05.004 · Cited by 72
Self-citationCircadian Variation in Serum CrossLaps Concentration Is Reduced in Fasting Individuals
Christgau, S. (2000) · Clinical Chemistry · doi:10.1093/clinchem/46.3.431a · Cited by 70
Gineyts, É., Mo, J. A., Ko, A., Henriksen, D. B., Curtis, S. P., Gertz, B. J., Garnero, P., & Delmas, P. D. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.007302 · Cited by 65
Self-citationTabassi, N. C.-B., & Garnero, P. (2007) · Current Rheumatology Reports · doi:10.1007/s11926-007-0017-y · Cited by 62
Self-citationGineyts, É., Garnero, P., & Delmas, P. D. (2001) · Rheumatology · doi:10.1093/rheumatology/40.3.315 · Cited by 59
Self-citationKing, K. B., Lindsey, C. T., Dunn, T. C., Ries, M. D., Steinbach, L. S., & Majumdar, S. (2004) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2004.08.001 · Cited by 57
Cibere, J., Thorne, A., Kopec, J. A., Singer, J., Canvin, J., Robinson, D. B., Pope, J. E., Hong, P., Grant, E., Lobanok, T., et al. (2005) · PubMed · Cited by 56
Self-citationSteinborn, L. (2004) · CRC Press eBooks · doi:10.3109/9780203026656-7 · Cited by 54
Accumlation of Hyaluronate in Human Lung Carcinoma As Measured by A new Hyaluronate Elisa
Li, X., Thonar, E. J.-M. A., & Knudson, W. (1989) · Connective Tissue Research · doi:10.3109/03008208909043899 · Cited by 52
Chua, S. D., Messier, S. P., Legault, C., Lenz, M. E., Thonar, E. J. ‐. A., & Loeser, R. F. (2008) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2008.02.002 · Cited by 52
Mullan, R. H., Matthews, C. H., Bresnihan, B., FitzGerald, O., King, L., Poole, A. R., Fearon, U., & Veale, D. J. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22843 · Cited by 50
Self-citationIsolation of Microarray-Grade Total RNA, MicroRNA, and DNA from a Single PAXgene Blood RNA Tube
Kruhøffer, M., Dyrskjøt, L., Voß, T., Lindberg, R. L. P., Wyrich, R., Thykjær, T., & Orntoft, T. F. (2007) · Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2007.060175 · Cited by 48
Collagen fibril disruption occurs early in primary guinea pig knee osteoarthritis
Huebner, J. L., Williams, J. M., Deberg, M. A., Henrotin, Y. E., & Kraus, V. B. (2009) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2009.09.011 · Cited by 46
Self-citationConrozier, T., Poole, A. R., Ferrand, F., Mathieu, P., Vincent, F., Piperno, M., Verret, C., Ionescu, M., & Vignon, E. P. (2008) · PubMed · Cited by 46
Self-citationModulation of Collagen Fibrillogenesis by Dentinal Proteoglycans
Milan, A. M., Sugars, R. V., Embery, G., & Waddington, R. J. (2004) · Calcified Tissue International · doi:10.1007/s00223-004-0033-0 · Cited by 45
Optimization of the fixed-flexion knee radiograph
Charles, H. C., Kraus, V. B., Ainslie, M., & Graverand, M.-P. H. L. (2007) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2007.05.012 · Cited by 45
Self-citationMazzuca, S. A., Poole, A. R., Brandt, K. D., Katz, B. P., Lane, K. A., & Lobanok, T. (2006) · PubMed · Cited by 44
Self-citationKobayashi, T., Yoshihara, Y., Samura, A., Yamada, H., Shinmei, M., Roos, H. P., & Lohmander, S. L. (1997) · Annals of the Rheumatic Diseases · doi:10.1136/ard.56.8.500 · Cited by 44
Blood-based biomarkers for detecting mild osteoarthritis in the human knee
Marshall, K. W., Zhang, H., Yager, T. D., Nossova, N., Dempsey, A. A., Zheng, R., Han, M., Tang, H.-C., Chao, S., & Liew, C. C. (2005) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2005.06.002 · Cited by 42
Collagen biomarkers for arthritis applications.
Birmingham, J. D., Vilı́m, V., & Kraus, V. B. (2007) · PubMed Central · Cited by 41
Self-citationGraverand, M.-P. H. L., Brandt, K. D., Mazzuca, S. A., Katz, B. P., Buck, R. J., Lane, K. A., Pickering, E., Nemirovskiy, O. V., Sunyer, T., & Welsch, D. (2006) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2006.04.009 · Cited by 39
Addison, S., Coleman, R. E., Feng, S., McDaniel, G. E., & Kraus, V. B. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24856 · Cited by 38
Self-citationMolecular markers of processes in cartilage in joint disease.
Heinegård, D. K., & Saxne, T. (1991) · PubMed · Cited by 38
Self-citationWhither osteoarthritis biomarkers?
Felson, D. T., & Lohmander, S. L. (2009) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2009.02.004 · Cited by 38
Markers of joint destruction: principles, problems, and potential
Young‐Min, S. A., CAWSTON, T. E., & GRIFFITHS, I. D. (2001) · Annals of the Rheumatic Diseases · doi:10.1136/ard.60.6.545a · Cited by 37
The Many Faces of Osteoarthritis
(2002) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8133-3 · Cited by 37
Variation in osteoarthritis biomarkers from activity not food consumption
Gordon, C. D., Stäbler, T., & Kraus, V. B. (2008) · Clinica Chimica Acta · doi:10.1016/j.cca.2008.07.031 · Cited by 36
Self-citationThe Food and Drug Administration's Osteoporosis Guidance Document: Past, Present, and Future
Colman, E. G. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.6.1125 · Cited by 29
Collagen Biomarkers for Arthritis Applications
Birmingham, J. D., Vilı́m, V., & Kraus, V. B. (2006) · Biomarker Insights · doi:10.1177/117727190600100011 · Cited by 29
Self-citationYamada, H., Miyauchi, S., Morita, M., Yoshida, Y., Yoshihara, Y., Kikuchi, T., Washimi, O., Washimi, Y., Terada, N., Seki, T., et al. (2000) · PubMed · Cited by 27
Leff, R. L., Elias, I., Ionescu, M., Reiner, A., & Poole, A. R. (2003) · PubMed · Cited by 27
Self-citationPlasma hyaluronan concentration: no circadian rhythm but large effect of food intake in humans
Rössler, A., L�szl�, Z., Kvas, E., & Hinghofer-Szalkay, H. G. (1998) · European Journal of Applied Physiology · doi:10.1007/s004210050463 · Cited by 26
Mazzuca, S. A., Brandt, K. D., Eyre, D. R., Katz, B. P., Askew, J., & Lane, K. A. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.041582 · Cited by 23
Self-citation(2008) · Biotechnology Law Report · doi:10.1089/blr.2008.9943 · Cited by 23
The Many Faces of Osteoarthritis
Lane, N. E., & Wallace, D. J. (2002) · doi:10.1093/oso/9780195138733.003.0010 · Cited by 23
Defining and validating the clinical role of molecular markers in osteoarthritis
Lohmander, S. L., & Poole, A. R. (2003) · Lund University Publications (Lund University) · Cited by 22
Self-citationBrune, K., Katus, H. A., Moecks, J., Spanuth, E., Jaffe, A. S., & Giannitsis, E. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.097428 · Cited by 22
PIIANP and HELIXII diurnal variation
Quintana, D. J., Garnero, P., Huebner, J. L., Tabassi, N. C.-B., & Kraus, V. B. (2008) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2008.03.006 · Cited by 22
Self-citationClinical Trials in Rheumatoid Arthritis and Osteoarthritis
Reid, D. M. (2008) · Springer eBooks · doi:10.1007/978-1-84628-742-8 · Cited by 22
Hasegawa, M., Nakoshi, Y., Tsujii, M., Sudo, A., Masuda, H., Yoshida, T., & Uchida, A. (2008) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2007.09.014 · Cited by 21
Otterness, I. G., Brandt, K. D., Graverand, M. H. L., & Mazzuca, S. A. (2007) · Arthritis & Rheumatism · doi:10.1002/art.23025 · Cited by 18
Poole, A. R., Oldham, G., & Coombs, R. R. A. (2009) · International Archives of Allergy and Applied Immunology · doi:10.1159/000232094 · Cited by 17
Self-citationBiochemical Markers as Surrogate End Points of Joint Disease
Lohmander, S. L., & Eyre, D. R. (2008) · Springer eBooks · doi:10.1007/978-1-84628-742-8_16 · Cited by 16
Self-citationEyre, D. R., & Weis, M. A. (2009) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2009.02.005 · Cited by 16
Self-citationŁukaszkiewicz, J., Karczmarewicz, E., Płudowski, P., Jaworski, M., Czerwinski, E. J., Lewiñski, A., Marcinowska-Suchowierska, E., Milewicz, A., Spaczyński, M., & Lorenc, R. S. (2008) · PubMed · Cited by 10
Collagen cross-links as markers of bone and cartilage degradation
Eyre, D. R., Atley, L. M., & Wu, J.-J. (2002) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8133-3_27 · Cited by 3
Self-citationGarnero, P., Gourley, I. S., Mareau, E., Durn, B. L., Hickey, L., & Cohen, S. L. (2007) · Osteoarthritis and Cartilage · doi:10.1016/s1063-4584(07)61740-3 · Cited by 2
Self-citationGriffiths, D. J., & Venables, P. J. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199911)42:11 · Cited by 1
Self-citation
Research works printed but not linked: 3
- Atley, 1998, Matrix metalloproteinase-mediated release of immunoreactive telopeptides from cartilage type II collagen, Trans Orthop Res Soc, 23, 850
- Norlund, 1997, Markers of bone type I and cartilage type II collagen degradation in the Hartley guinea pig model of osteoarthritis, Trans Orthop Res, 22, 313
- Krasnokutsky, 2007, Peripheral blood leukocyte gene expression as biomarkers of disease in knee osteoarthritis (OA), Arthritis Rheum, 56
Cited by
Sorted by citations
Kraus, V. B., Blanco, F. J., Englund, M., Karsdal, M. A., & Lohmander, S. L. (2015) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2015.03.036 · Cited by 663
Self-citationAnimal Models of Osteoarthritis
McCoy, A. M. (2015) · Veterinary Pathology · doi:10.1177/0300985815588611 · Cited by 655
Animal models of osteoarthritis: classification, update, and measurement of outcomes
Kuyinu, E. L., Narayanan, G., Nair, L. S., & Laurencin, C. T. (2016) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-016-0346-5 · Cited by 587
Early-stage symptomatic osteoarthritis of the knee — time for action
Mahmoudian, A., Lohmander, S. L., Mobasheri, A., Englund, M., & Luyten, F. P. (2021) · Nature Reviews Rheumatology · doi:10.1038/s41584-021-00673-4 · Cited by 469
Goldring, M. B. (2012) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x12448454 · Cited by 470
Metadata
- Authors
- Kraus, V. B., Burnett, B., Coindreau, J., Cottrell, S., Eyre, D., Gendreau, M., Gardiner, J., Garnero, P., Hardin, J., Henrotin, Y., Heinegård, D., Ko, A., Lohmander, L. S., Matthews, G., Menetski, J., Moskowitz, R., Persiani, S., Poole, A. R., Rousseau, J.-C., & Todman, M.
- Affiliations
- Duke Medical Center (US)
- Duke University (US)
- Amgen (United States) (US)
- University of Washington (US)
- Wyeth (US)
- Inserm (FR)
- Albert Einstein College of Medicine (US)
- University of Liège (BE)
- Lund University (SE)
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Case Western Reserve University (US)
- McGill University (CA)
- Hospices Civils de Lyon (FR)
- Smith & Nephew (United Kingdom) (GB)
- Corresponding author
- Kraus, V.B.
- Venue
- Osteoarthritis and Cartilage
- Publisher
- Elsevier BV
- Published
- 2011-05
- Volume
- 19
- Issue
- 5
- Pages
- 515-542
- ISSN
- 1063-4584 (ISSN-L)
- PMC
- PMC3568396
- OpenAlex
- W2059670411
- Cited by
- 328
- References
- 129
- Citations by year
- 2026: 11 · 2025: 20 · 2024: 17 · 2023: 17 · 2022: 23 · 2021: 23 · 2020: 15 · 2019: 20 · 2018: 13 · 2017: 23 · 2016: 24 · 2015: 35 · 2014: 25 · 2013: 26 · 2012: 24
- FWCI
- 19.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Osteoarthritis and Cartilage (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Lund University Publications (Lund University) (submittedVersion, other-oa)
- ORBi (University of Liège) (submittedVersion)
- Funders
- National Institute on Aging (P30AG028716)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR 50245, P01AR050245)
- National Center for Research Resources (UL1RR024128)
- Topics
- Health Sciences › Medicine › Rheumatology › Osteoarthritis Treatment and Mechanisms
- Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Musculoskeletal pain and rehabilitation
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacological Effects of Medicinal Plants
- Keywords
- osteoarthritis, biomarkers, drug development, biomarker qualification, prognostic factors, treatment response monitoring, clinical trial outcome measures, drug discovery
- MeSH terms
- Clinical Trials as Topic, Humans, Osteoarthritis, Specimen Handling, Biomarkers, Treatment Outcome, Drug Monitoring, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
